Latest Articlesddd
We are currently working to bring into the upcoming ProhostBiotech Letter some small clinical and commercial …
AbbiVie Inc's Acquisition and Approval 1. AbbVie's Acquisition AbbVie Inc. (ABBV) and Landos Biopharma, Inc. …
Novo Nordisk in the NEWS Novo Nordisk (NVO) and Cardior Pharmaceuticals announced that Novo Nordisk agreed …
Italfarmaco in the NEWS From Milan, Italy: Today, Italfarmaco announced that the U.S. Food and Drug …
Illumina in the NEWS On March 21, 2024, we learned that the EU antitrust regulators suffered …
During a discussion with colleagues about the best way to select small and new biotechnology firms …
Madrigal Pharmaceuticals in the NEWS Yesterday, March 14, 2024 Madrigal Pharmaceuticals (MDGL) announced that the U.S. …
The Market Today the Stock Market is bearish and most of the biotech stocks are down …
Arcturus Therapeutics Fourth Quarter and Full Year 2023 Earnings Conference Call Before listening to the Conference …
Compugen in the NEWS Compugen (CGEN) offered its fourth Quarter and full year 2023 results yesterday, …
BioCardia Inc in the NEWS BioCardia, Inc. (BCDA), a biotechnology company focused on advancing late-stage cell therapy …
Akero Therapeutics Akero Therapeutics (AKRO) released preliminary topline week 96 results from HARMONY, a Phase 2b …
Prohost Letter #459 ~ NAFLD & NASH NAFLD is Non-Alcoholic Fatty Liver Disease, and NASH is …
Verrica Pharmaceuticals Verrica Pharmaceuticals (VRCA) is a dermatology therapeutics company developing medications for skin diseases. …
Krystal Biotech Today, February 26, 2024, Krystal Biotech (KRYS) firm announces its full year financial results …
Vertex Pharmaceuticals in the NEWS Vertex Pharmaceuticals (VRTX) announced that the European Medicines Agency’s (EMA’s) Committee …
CRISPR Therapeutics Since its inception over a decade ago, CRISPR Therapeutics (CRSP) has transformed from a …
Ionis Pharmaceuticals For three decades, Ionis Pharmaceuticals (IONS) invented medicines to treat serious diseases. Currently, Ionis …
Travere Therapeutics in the NEWS Yesterday, Feb. 15, 2024, Travere Therapeutics, Inc. (TVTX) reported its fourth …
Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readiness …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
